| Business Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Recognizing The Talents in Our Own Midst |
|
Business Articles - Recognizing The Talents in Our Own Midst
According to experts in the field of hiring and training development, there is a great potential withi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product n our own companies for talented individuals. Why are we not recognizing those already in our midst? ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in An explanation is: when people are working at lower levels than their management abilities, we can’t lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. see what they can really do. And in this day and age, we have a lot of people laid off from downsized here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe companies who have to take lower level positions for survival. We just don’t recognize who’s working d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro for us or with us. We limit our people by their current titles, functions and departments. Yet getti ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ng to know our people is not hard to do – we just need to talk to them! It’s up to management to init easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ate such talks. Some companies have implemented “Talent Development Programs”. What we really need a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically re “Talent Recognition Programs”. Management needs to take the time to recognize whom we have amongst and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ those employees currently working as “latent talent”. There are scores of qualified, skilled individ ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi als who have had to take on jobs many levels below their business capabilities and experiences because ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a of economic downturn or simply because nobody has recognized their abilities and given them a chance dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod to prove themselves. Dig up your employees’ resumes again, from the interviewer’s forgotten files, an cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin d get familiar with them. Let’s not leave these highly personal information papers to die in the afte tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen math of the initial interview. Then let’s talk to our people and ask the right questions. Test with t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel projects that the individual can work on for short periods of time – say a week, a month or three mont ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust hs and find out what they can do. All this should happen with proper delegating, empowerment and regu y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ar meetings. Finally, let’s assess ourselves and REGOGNIZE the assets that we have in our people. /e . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nd of article. You may print this article in your ezine or web site or pass it on to others providing elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip nothing is changed and the bio is fully included at the end of the article. Diane M. Hoffmann(c)2002 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Benefits of Defending Yourself with a Pepper Spray Five Tips for Using Automatic Spanish Translation Tools
|